Back for good

Posted:
16
June 2004

RPL is delighted to welcome Clinical Trials Assistant, Bibbi Jilka back to the company after a short spell at Parexel. Bibbi first joined RPL in 2002, having previously worked with Managing Director, Dr Jörg Täubel and Medical Director, Ulrike Lorch at another company. She returned to RPL after just seven months at Parexel.‘I missed RPL's warm friendly environment. It is really exciting to work within a multidisciplinary team with direct access to the Medical Director and the Head Nurse. I am learning all the time and making the most of my training.’In the turn the RPL Directors are pleased to have Bibbi back. Jörg Täubel said, ‘it's very rewarding to hear that RPL offers a stimulating work environment. We want to develop staff to their maximum potential with good training and as much encouragement as possible. We've known Bibbi for a long time and it's great to have her back.’

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more